Global Octreotide Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Octreotide market size is predicted to grow from US$ 2.8 million in 2025 to US$ 2.3 million in 2031; it is expected to grow at a CAGR of -2.9% from 2025 to 2031.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically?it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
LP Information, Inc. (LPI) ' newest research report, the “Octreotide Industry Forecast” looks at past sales and reviews total world Octreotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Octreotide sales for 2025 through 2031. With Octreotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Octreotide industry.
This Insight Report provides a comprehensive analysis of the global Octreotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Octreotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Octreotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Octreotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Octreotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Octreotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Octreotide market?
What factors are driving Octreotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Octreotide market opportunities vary by end market size?
How does Octreotide break out by Type, by Application?
The global Octreotide market size is predicted to grow from US$ 2.8 million in 2025 to US$ 2.3 million in 2031; it is expected to grow at a CAGR of -2.9% from 2025 to 2031.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically?it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
LP Information, Inc. (LPI) ' newest research report, the “Octreotide Industry Forecast” looks at past sales and reviews total world Octreotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Octreotide sales for 2025 through 2031. With Octreotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Octreotide industry.
This Insight Report provides a comprehensive analysis of the global Octreotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Octreotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Octreotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Octreotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Octreotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Octreotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
What is the 10-year outlook for the global Octreotide market?
What factors are driving Octreotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Octreotide market opportunities vary by end market size?
How does Octreotide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Octreotide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Octreotide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Octreotide by Country/Region, 2020, 2024 & 2031
2.2 Octreotide Segment by Type
2.2.1 Octreotide Injection
2.2.2 Octreotide Powder
2.2.3 Octreotide Microspheres
2.3 Octreotide Sales by Type
2.3.1 Global Octreotide Sales Market Share by Type (2020-2025)
2.3.2 Global Octreotide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Octreotide Sale Price by Type (2020-2025)
2.4 Octreotide Segment by Application
2.4.1 Treating Severe Diarrhea
2.4.2 Treating Acromegaly
2.4.3 Others
2.5 Octreotide Sales by Application
2.5.1 Global Octreotide Sale Market Share by Application (2020-2025)
2.5.2 Global Octreotide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Octreotide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Octreotide Breakdown Data by Company
3.1.1 Global Octreotide Annual Sales by Company (2020-2025)
3.1.2 Global Octreotide Sales Market Share by Company (2020-2025)
3.2 Global Octreotide Annual Revenue by Company (2020-2025)
3.2.1 Global Octreotide Revenue by Company (2020-2025)
3.2.2 Global Octreotide Revenue Market Share by Company (2020-2025)
3.3 Global Octreotide Sale Price by Company
3.4 Key Manufacturers Octreotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Octreotide Product Location Distribution
3.4.2 Players Octreotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OCTREOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Octreotide Market Size by Geographic Region (2020-2025)
4.1.1 Global Octreotide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Octreotide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Octreotide Market Size by Country/Region (2020-2025)
4.2.1 Global Octreotide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Octreotide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Octreotide Sales Growth
4.4 APAC Octreotide Sales Growth
4.5 Europe Octreotide Sales Growth
4.6 Middle East & Africa Octreotide Sales Growth
5 AMERICAS
5.1 Americas Octreotide Sales by Country
5.1.1 Americas Octreotide Sales by Country (2020-2025)
5.1.2 Americas Octreotide Revenue by Country (2020-2025)
5.2 Americas Octreotide Sales by Type (2020-2025)
5.3 Americas Octreotide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Octreotide Sales by Region
6.1.1 APAC Octreotide Sales by Region (2020-2025)
6.1.2 APAC Octreotide Revenue by Region (2020-2025)
6.2 APAC Octreotide Sales by Type (2020-2025)
6.3 APAC Octreotide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Octreotide by Country
7.1.1 Europe Octreotide Sales by Country (2020-2025)
7.1.2 Europe Octreotide Revenue by Country (2020-2025)
7.2 Europe Octreotide Sales by Type (2020-2025)
7.3 Europe Octreotide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Octreotide by Country
8.1.1 Middle East & Africa Octreotide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Octreotide Revenue by Country (2020-2025)
8.2 Middle East & Africa Octreotide Sales by Type (2020-2025)
8.3 Middle East & Africa Octreotide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Octreotide
10.3 Manufacturing Process Analysis of Octreotide
10.4 Industry Chain Structure of Octreotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Octreotide Distributors
11.3 Octreotide Customer
12 WORLD FORECAST REVIEW FOR OCTREOTIDE BY GEOGRAPHIC REGION
12.1 Global Octreotide Market Size Forecast by Region
12.1.1 Global Octreotide Forecast by Region (2026-2031)
12.1.2 Global Octreotide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Octreotide Forecast by Type (2026-2031)
12.7 Global Octreotide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Octreotide Product Portfolios and Specifications
13.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Octreotide Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Chengdu Tiantaishan pharmaceutical
13.3.1 Chengdu Tiantaishan pharmaceutical Company Information
13.3.2 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolios and Specifications
13.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chengdu Tiantaishan pharmaceutical Main Business Overview
13.3.5 Chengdu Tiantaishan pharmaceutical Latest Developments
13.4 Sinopharm A-Think Pharmaceuticals
13.4.1 Sinopharm A-Think Pharmaceuticals Company Information
13.4.2 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications
13.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinopharm A-Think Pharmaceuticals Main Business Overview
13.4.5 Sinopharm A-Think Pharmaceuticals Latest Developments
13.5 Sihuan Pharmaceutical Holdings Group
13.5.1 Sihuan Pharmaceutical Holdings Group Company Information
13.5.2 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications
13.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sihuan Pharmaceutical Holdings Group Main Business Overview
13.5.5 Sihuan Pharmaceutical Holdings Group Latest Developments
13.6 Shanghai Soho-Yiming Pharmaceuticals
13.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
13.6.2 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications
13.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Soho-Yiming Pharmaceuticals Main Business Overview
13.6.5 Shanghai Soho-Yiming Pharmaceuticals Latest Developments
13.7 Yibin Pharmaceutical
13.7.1 Yibin Pharmaceutical Company Information
13.7.2 Yibin Pharmaceutical Octreotide Product Portfolios and Specifications
13.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yibin Pharmaceutical Main Business Overview
13.7.5 Yibin Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Octreotide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Octreotide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Octreotide Injection
Table 4. Major Players of Octreotide Powder
Table 5. Major Players of Octreotide Microspheres
Table 6. Global Octreotide Sales byType (2020-2025) & (Gram)
Table 7. Global Octreotide Sales Market Share byType (2020-2025)
Table 8. Global Octreotide Revenue byType (2020-2025) & ($ million)
Table 9. Global Octreotide Revenue Market Share byType (2020-2025)
Table 10. Global Octreotide Sale Price byType (2020-2025) & (USD/Gram)
Table 11. Global Octreotide Sale by Application (2020-2025) & (Gram)
Table 12. Global Octreotide Sale Market Share by Application (2020-2025)
Table 13. Global Octreotide Revenue by Application (2020-2025) & ($ million)
Table 14. Global Octreotide Revenue Market Share by Application (2020-2025)
Table 15. Global Octreotide Sale Price by Application (2020-2025) & (USD/Gram)
Table 16. Global Octreotide Sales by Company (2020-2025) & (Gram)
Table 17. Global Octreotide Sales Market Share by Company (2020-2025)
Table 18. Global Octreotide Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Octreotide Revenue Market Share by Company (2020-2025)
Table 20. Global Octreotide Sale Price by Company (2020-2025) & (USD/Gram)
Table 21. Key Manufacturers Octreotide Producing Area Distribution and Sales Area
Table 22. Players Octreotide Products Offered
Table 23. Octreotide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Octreotide Sales by Geographic Region (2020-2025) & (Gram)
Table 27. Global Octreotide Sales Market Share Geographic Region (2020-2025)
Table 28. Global Octreotide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Octreotide Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Octreotide Sales by Country/Region (2020-2025) & (Gram)
Table 31. Global Octreotide Sales Market Share by Country/Region (2020-2025)
Table 32. Global Octreotide Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Octreotide Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Octreotide Sales by Country (2020-2025) & (Gram)
Table 35. Americas Octreotide Sales Market Share by Country (2020-2025)
Table 36. Americas Octreotide Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Octreotide Sales byType (2020-2025) & (Gram)
Table 38. Americas Octreotide Sales by Application (2020-2025) & (Gram)
Table 39. APAC Octreotide Sales by Region (2020-2025) & (Gram)
Table 40. APAC Octreotide Sales Market Share by Region (2020-2025)
Table 41. APAC Octreotide Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Octreotide Sales byType (2020-2025) & (Gram)
Table 43. APAC Octreotide Sales by Application (2020-2025) & (Gram)
Table 44. Europe Octreotide Sales by Country (2020-2025) & (Gram)
Table 45. Europe Octreotide Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Octreotide Sales byType (2020-2025) & (Gram)
Table 47. Europe Octreotide Sales by Application (2020-2025) & (Gram)
Table 48. Middle East & Africa Octreotide Sales by Country (2020-2025) & (Gram)
Table 49. Middle East & Africa Octreotide Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Octreotide Sales byType (2020-2025) & (Gram)
Table 51. Middle East & Africa Octreotide Sales by Application (2020-2025) & (Gram)
Table 52. Key Market Drivers & Growth Opportunities of Octreotide
Table 53. Key Market Challenges & Risks of Octreotide
Table 54. Key IndustryTrends of Octreotide
Table 55. Octreotide Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Octreotide Distributors List
Table 58. Octreotide Customer List
Table 59. Global Octreotide SalesForecast by Region (2026-2031) & (Gram)
Table 60. Global Octreotide RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 62. Americas Octreotide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Octreotide SalesForecast by Region (2026-2031) & (Gram)
Table 64. APAC Octreotide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 66. Europe Octreotide RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 68. Middle East & Africa Octreotide RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Octreotide SalesForecast byType (2026-2031) & (Gram)
Table 70. Global Octreotide RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Octreotide SalesForecast by Application (2026-2031) & (Gram)
Table 72. Global Octreotide RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Octreotide Product Portfolios and Specifications
Table 75. Novartis Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Sun Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 79. Sun Pharmaceutical Octreotide Product Portfolios and Specifications
Table 80. Sun Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 81. Sun Pharmaceutical Main Business
Table 82. Sun Pharmaceutical Latest Developments
Table 83. ChengduTiantaishan pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 84. ChengduTiantaishan pharmaceutical Octreotide Product Portfolios and Specifications
Table 85. ChengduTiantaishan pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 86. ChengduTiantaishan pharmaceutical Main Business
Table 87. ChengduTiantaishan pharmaceutical Latest Developments
Table 88. Sinopharm A-Think Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 89. Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications
Table 90. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 91. Sinopharm A-Think Pharmaceuticals Main Business
Table 92. Sinopharm A-Think Pharmaceuticals Latest Developments
Table 93. Sihuan Pharmaceutical Holdings Group Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications
Table 95. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 96. Sihuan Pharmaceutical Holdings Group Main Business
Table 97. Sihuan Pharmaceutical Holdings Group Latest Developments
Table 98. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications
Table 100. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 101. Shanghai Soho-Yiming Pharmaceuticals Main Business
Table 102. Shanghai Soho-Yiming Pharmaceuticals Latest Developments
Table 103. Yibin Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 104. Yibin Pharmaceutical Octreotide Product Portfolios and Specifications
Table 105. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 106. Yibin Pharmaceutical Main Business
Table 107. Yibin Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Octreotide
Figure 2. Octreotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Octreotide Sales Growth Rate 2020-2031 (Gram)
Figure 7. Global Octreotide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Octreotide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Octreotide Sales Market Share by Country/Region (2024)
Figure 10. Octreotide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Octreotide Injection
Figure 12. Product Picture of Octreotide Powder
Figure 13. Product Picture of Octreotide Microspheres
Figure 14. Global Octreotide Sales Market Share byType in 2025
Figure 15. Global Octreotide Revenue Market Share byType (2020-2025)
Figure 16. Octreotide Consumed inTreating Severe Diarrhea
Figure 17. Global Octreotide Market:Treating Severe Diarrhea (2020-2025) & (Gram)
Figure 18. Octreotide Consumed inTreating Acromegaly
Figure 19. Global Octreotide Market:Treating Acromegaly (2020-2025) & (Gram)
Figure 20. Octreotide Consumed in Others
Figure 21. Global Octreotide Market: Others (2020-2025) & (Gram)
Figure 22. Global Octreotide Sale Market Share by Application (2024)
Figure 23. Global Octreotide Revenue Market Share by Application in 2025
Figure 24. Octreotide Sales by Company in 2025 (Gram)
Figure 25. Global Octreotide Sales Market Share by Company in 2025
Figure 26. Octreotide Revenue by Company in 2025 ($ millions)
Figure 27. Global Octreotide Revenue Market Share by Company in 2025
Figure 28. Global Octreotide Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Octreotide Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Octreotide Sales 2020-2025 (Gram)
Figure 31. Americas Octreotide Revenue 2020-2025 ($ millions)
Figure 32. APAC Octreotide Sales 2020-2025 (Gram)
Figure 33. APAC Octreotide Revenue 2020-2025 ($ millions)
Figure 34. Europe Octreotide Sales 2020-2025 (Gram)
Figure 35. Europe Octreotide Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Octreotide Sales 2020-2025 (Gram)
Figure 37. Middle East & Africa Octreotide Revenue 2020-2025 ($ millions)
Figure 38. Americas Octreotide Sales Market Share by Country in 2025
Figure 39. Americas Octreotide Revenue Market Share by Country (2020-2025)
Figure 40. Americas Octreotide Sales Market Share byType (2020-2025)
Figure 41. Americas Octreotide Sales Market Share by Application (2020-2025)
Figure 42. United States Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Octreotide Sales Market Share by Region in 2025
Figure 47. APAC Octreotide Revenue Market Share by Region (2020-2025)
Figure 48. APAC Octreotide Sales Market Share byType (2020-2025)
Figure 49. APAC Octreotide Sales Market Share by Application (2020-2025)
Figure 50. China Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 54. India Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Octreotide Sales Market Share by Country in 2025
Figure 58. Europe Octreotide Revenue Market Share by Country (2020-2025)
Figure 59. Europe Octreotide Sales Market Share byType (2020-2025)
Figure 60. Europe Octreotide Sales Market Share by Application (2020-2025)
Figure 61. Germany Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 62.France Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Octreotide Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Octreotide Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Octreotide Sales Market Share by Application (2020-2025)
Figure 69. Egypt Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Octreotide in 2025
Figure 75. Manufacturing Process Analysis of Octreotide
Figure 76. Industry Chain Structure of Octreotide
Figure 77. Channels of Distribution
Figure 78. Global Octreotide Sales MarketForecast by Region (2026-2031)
Figure 79. Global Octreotide Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Octreotide Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Octreotide Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Octreotide Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Octreotide Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Octreotide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Octreotide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Octreotide by Country/Region, 2020, 2024 & 2031
2.2 Octreotide Segment by Type
2.2.1 Octreotide Injection
2.2.2 Octreotide Powder
2.2.3 Octreotide Microspheres
2.3 Octreotide Sales by Type
2.3.1 Global Octreotide Sales Market Share by Type (2020-2025)
2.3.2 Global Octreotide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Octreotide Sale Price by Type (2020-2025)
2.4 Octreotide Segment by Application
2.4.1 Treating Severe Diarrhea
2.4.2 Treating Acromegaly
2.4.3 Others
2.5 Octreotide Sales by Application
2.5.1 Global Octreotide Sale Market Share by Application (2020-2025)
2.5.2 Global Octreotide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Octreotide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Octreotide Breakdown Data by Company
3.1.1 Global Octreotide Annual Sales by Company (2020-2025)
3.1.2 Global Octreotide Sales Market Share by Company (2020-2025)
3.2 Global Octreotide Annual Revenue by Company (2020-2025)
3.2.1 Global Octreotide Revenue by Company (2020-2025)
3.2.2 Global Octreotide Revenue Market Share by Company (2020-2025)
3.3 Global Octreotide Sale Price by Company
3.4 Key Manufacturers Octreotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Octreotide Product Location Distribution
3.4.2 Players Octreotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OCTREOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Octreotide Market Size by Geographic Region (2020-2025)
4.1.1 Global Octreotide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Octreotide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Octreotide Market Size by Country/Region (2020-2025)
4.2.1 Global Octreotide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Octreotide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Octreotide Sales Growth
4.4 APAC Octreotide Sales Growth
4.5 Europe Octreotide Sales Growth
4.6 Middle East & Africa Octreotide Sales Growth
5 AMERICAS
5.1 Americas Octreotide Sales by Country
5.1.1 Americas Octreotide Sales by Country (2020-2025)
5.1.2 Americas Octreotide Revenue by Country (2020-2025)
5.2 Americas Octreotide Sales by Type (2020-2025)
5.3 Americas Octreotide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Octreotide Sales by Region
6.1.1 APAC Octreotide Sales by Region (2020-2025)
6.1.2 APAC Octreotide Revenue by Region (2020-2025)
6.2 APAC Octreotide Sales by Type (2020-2025)
6.3 APAC Octreotide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Octreotide by Country
7.1.1 Europe Octreotide Sales by Country (2020-2025)
7.1.2 Europe Octreotide Revenue by Country (2020-2025)
7.2 Europe Octreotide Sales by Type (2020-2025)
7.3 Europe Octreotide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Octreotide by Country
8.1.1 Middle East & Africa Octreotide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Octreotide Revenue by Country (2020-2025)
8.2 Middle East & Africa Octreotide Sales by Type (2020-2025)
8.3 Middle East & Africa Octreotide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Octreotide
10.3 Manufacturing Process Analysis of Octreotide
10.4 Industry Chain Structure of Octreotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Octreotide Distributors
11.3 Octreotide Customer
12 WORLD FORECAST REVIEW FOR OCTREOTIDE BY GEOGRAPHIC REGION
12.1 Global Octreotide Market Size Forecast by Region
12.1.1 Global Octreotide Forecast by Region (2026-2031)
12.1.2 Global Octreotide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Octreotide Forecast by Type (2026-2031)
12.7 Global Octreotide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Octreotide Product Portfolios and Specifications
13.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Octreotide Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Chengdu Tiantaishan pharmaceutical
13.3.1 Chengdu Tiantaishan pharmaceutical Company Information
13.3.2 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolios and Specifications
13.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chengdu Tiantaishan pharmaceutical Main Business Overview
13.3.5 Chengdu Tiantaishan pharmaceutical Latest Developments
13.4 Sinopharm A-Think Pharmaceuticals
13.4.1 Sinopharm A-Think Pharmaceuticals Company Information
13.4.2 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications
13.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinopharm A-Think Pharmaceuticals Main Business Overview
13.4.5 Sinopharm A-Think Pharmaceuticals Latest Developments
13.5 Sihuan Pharmaceutical Holdings Group
13.5.1 Sihuan Pharmaceutical Holdings Group Company Information
13.5.2 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications
13.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sihuan Pharmaceutical Holdings Group Main Business Overview
13.5.5 Sihuan Pharmaceutical Holdings Group Latest Developments
13.6 Shanghai Soho-Yiming Pharmaceuticals
13.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
13.6.2 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications
13.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Soho-Yiming Pharmaceuticals Main Business Overview
13.6.5 Shanghai Soho-Yiming Pharmaceuticals Latest Developments
13.7 Yibin Pharmaceutical
13.7.1 Yibin Pharmaceutical Company Information
13.7.2 Yibin Pharmaceutical Octreotide Product Portfolios and Specifications
13.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yibin Pharmaceutical Main Business Overview
13.7.5 Yibin Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Octreotide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Octreotide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Octreotide Injection
Table 4. Major Players of Octreotide Powder
Table 5. Major Players of Octreotide Microspheres
Table 6. Global Octreotide Sales byType (2020-2025) & (Gram)
Table 7. Global Octreotide Sales Market Share byType (2020-2025)
Table 8. Global Octreotide Revenue byType (2020-2025) & ($ million)
Table 9. Global Octreotide Revenue Market Share byType (2020-2025)
Table 10. Global Octreotide Sale Price byType (2020-2025) & (USD/Gram)
Table 11. Global Octreotide Sale by Application (2020-2025) & (Gram)
Table 12. Global Octreotide Sale Market Share by Application (2020-2025)
Table 13. Global Octreotide Revenue by Application (2020-2025) & ($ million)
Table 14. Global Octreotide Revenue Market Share by Application (2020-2025)
Table 15. Global Octreotide Sale Price by Application (2020-2025) & (USD/Gram)
Table 16. Global Octreotide Sales by Company (2020-2025) & (Gram)
Table 17. Global Octreotide Sales Market Share by Company (2020-2025)
Table 18. Global Octreotide Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Octreotide Revenue Market Share by Company (2020-2025)
Table 20. Global Octreotide Sale Price by Company (2020-2025) & (USD/Gram)
Table 21. Key Manufacturers Octreotide Producing Area Distribution and Sales Area
Table 22. Players Octreotide Products Offered
Table 23. Octreotide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Octreotide Sales by Geographic Region (2020-2025) & (Gram)
Table 27. Global Octreotide Sales Market Share Geographic Region (2020-2025)
Table 28. Global Octreotide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Octreotide Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Octreotide Sales by Country/Region (2020-2025) & (Gram)
Table 31. Global Octreotide Sales Market Share by Country/Region (2020-2025)
Table 32. Global Octreotide Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Octreotide Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Octreotide Sales by Country (2020-2025) & (Gram)
Table 35. Americas Octreotide Sales Market Share by Country (2020-2025)
Table 36. Americas Octreotide Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Octreotide Sales byType (2020-2025) & (Gram)
Table 38. Americas Octreotide Sales by Application (2020-2025) & (Gram)
Table 39. APAC Octreotide Sales by Region (2020-2025) & (Gram)
Table 40. APAC Octreotide Sales Market Share by Region (2020-2025)
Table 41. APAC Octreotide Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Octreotide Sales byType (2020-2025) & (Gram)
Table 43. APAC Octreotide Sales by Application (2020-2025) & (Gram)
Table 44. Europe Octreotide Sales by Country (2020-2025) & (Gram)
Table 45. Europe Octreotide Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Octreotide Sales byType (2020-2025) & (Gram)
Table 47. Europe Octreotide Sales by Application (2020-2025) & (Gram)
Table 48. Middle East & Africa Octreotide Sales by Country (2020-2025) & (Gram)
Table 49. Middle East & Africa Octreotide Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Octreotide Sales byType (2020-2025) & (Gram)
Table 51. Middle East & Africa Octreotide Sales by Application (2020-2025) & (Gram)
Table 52. Key Market Drivers & Growth Opportunities of Octreotide
Table 53. Key Market Challenges & Risks of Octreotide
Table 54. Key IndustryTrends of Octreotide
Table 55. Octreotide Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Octreotide Distributors List
Table 58. Octreotide Customer List
Table 59. Global Octreotide SalesForecast by Region (2026-2031) & (Gram)
Table 60. Global Octreotide RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 62. Americas Octreotide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Octreotide SalesForecast by Region (2026-2031) & (Gram)
Table 64. APAC Octreotide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 66. Europe Octreotide RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Octreotide SalesForecast by Country (2026-2031) & (Gram)
Table 68. Middle East & Africa Octreotide RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Octreotide SalesForecast byType (2026-2031) & (Gram)
Table 70. Global Octreotide RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Octreotide SalesForecast by Application (2026-2031) & (Gram)
Table 72. Global Octreotide RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Octreotide Product Portfolios and Specifications
Table 75. Novartis Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Sun Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 79. Sun Pharmaceutical Octreotide Product Portfolios and Specifications
Table 80. Sun Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 81. Sun Pharmaceutical Main Business
Table 82. Sun Pharmaceutical Latest Developments
Table 83. ChengduTiantaishan pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 84. ChengduTiantaishan pharmaceutical Octreotide Product Portfolios and Specifications
Table 85. ChengduTiantaishan pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 86. ChengduTiantaishan pharmaceutical Main Business
Table 87. ChengduTiantaishan pharmaceutical Latest Developments
Table 88. Sinopharm A-Think Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 89. Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications
Table 90. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 91. Sinopharm A-Think Pharmaceuticals Main Business
Table 92. Sinopharm A-Think Pharmaceuticals Latest Developments
Table 93. Sihuan Pharmaceutical Holdings Group Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications
Table 95. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 96. Sihuan Pharmaceutical Holdings Group Main Business
Table 97. Sihuan Pharmaceutical Holdings Group Latest Developments
Table 98. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications
Table 100. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 101. Shanghai Soho-Yiming Pharmaceuticals Main Business
Table 102. Shanghai Soho-Yiming Pharmaceuticals Latest Developments
Table 103. Yibin Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors
Table 104. Yibin Pharmaceutical Octreotide Product Portfolios and Specifications
Table 105. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 106. Yibin Pharmaceutical Main Business
Table 107. Yibin Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Octreotide
Figure 2. Octreotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Octreotide Sales Growth Rate 2020-2031 (Gram)
Figure 7. Global Octreotide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Octreotide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Octreotide Sales Market Share by Country/Region (2024)
Figure 10. Octreotide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Octreotide Injection
Figure 12. Product Picture of Octreotide Powder
Figure 13. Product Picture of Octreotide Microspheres
Figure 14. Global Octreotide Sales Market Share byType in 2025
Figure 15. Global Octreotide Revenue Market Share byType (2020-2025)
Figure 16. Octreotide Consumed inTreating Severe Diarrhea
Figure 17. Global Octreotide Market:Treating Severe Diarrhea (2020-2025) & (Gram)
Figure 18. Octreotide Consumed inTreating Acromegaly
Figure 19. Global Octreotide Market:Treating Acromegaly (2020-2025) & (Gram)
Figure 20. Octreotide Consumed in Others
Figure 21. Global Octreotide Market: Others (2020-2025) & (Gram)
Figure 22. Global Octreotide Sale Market Share by Application (2024)
Figure 23. Global Octreotide Revenue Market Share by Application in 2025
Figure 24. Octreotide Sales by Company in 2025 (Gram)
Figure 25. Global Octreotide Sales Market Share by Company in 2025
Figure 26. Octreotide Revenue by Company in 2025 ($ millions)
Figure 27. Global Octreotide Revenue Market Share by Company in 2025
Figure 28. Global Octreotide Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Octreotide Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Octreotide Sales 2020-2025 (Gram)
Figure 31. Americas Octreotide Revenue 2020-2025 ($ millions)
Figure 32. APAC Octreotide Sales 2020-2025 (Gram)
Figure 33. APAC Octreotide Revenue 2020-2025 ($ millions)
Figure 34. Europe Octreotide Sales 2020-2025 (Gram)
Figure 35. Europe Octreotide Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Octreotide Sales 2020-2025 (Gram)
Figure 37. Middle East & Africa Octreotide Revenue 2020-2025 ($ millions)
Figure 38. Americas Octreotide Sales Market Share by Country in 2025
Figure 39. Americas Octreotide Revenue Market Share by Country (2020-2025)
Figure 40. Americas Octreotide Sales Market Share byType (2020-2025)
Figure 41. Americas Octreotide Sales Market Share by Application (2020-2025)
Figure 42. United States Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Octreotide Sales Market Share by Region in 2025
Figure 47. APAC Octreotide Revenue Market Share by Region (2020-2025)
Figure 48. APAC Octreotide Sales Market Share byType (2020-2025)
Figure 49. APAC Octreotide Sales Market Share by Application (2020-2025)
Figure 50. China Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 54. India Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Octreotide Sales Market Share by Country in 2025
Figure 58. Europe Octreotide Revenue Market Share by Country (2020-2025)
Figure 59. Europe Octreotide Sales Market Share byType (2020-2025)
Figure 60. Europe Octreotide Sales Market Share by Application (2020-2025)
Figure 61. Germany Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 62.France Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Octreotide Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Octreotide Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Octreotide Sales Market Share by Application (2020-2025)
Figure 69. Egypt Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Octreotide Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Octreotide in 2025
Figure 75. Manufacturing Process Analysis of Octreotide
Figure 76. Industry Chain Structure of Octreotide
Figure 77. Channels of Distribution
Figure 78. Global Octreotide Sales MarketForecast by Region (2026-2031)
Figure 79. Global Octreotide Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Octreotide Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Octreotide Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Octreotide Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Octreotide Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Azithromycin Drug Market Growth 2025-2031
US$ 3,660.00
October 2025
118 pages
Global Specimen Validity Test (SVT) Reagents Market Growth 2024-2030
US$ 3,660.00
March 2024
117 pages
Global In-vitro Toxicity Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
95 pages
Global Primary Cell Culture Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
April 2026
107 pages
